Rapid Therapeutic Science Laboratories, Inc. (RTSL)
OTCMKTS · Delayed Price · Currency is USD
0.0074
0.00 (0.00%)
At close: Apr 24, 2025

RTSL Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2022 FY 2021 FY 2020 FY 2020 FY 2019 2014 - 2018
Period Ending
Apr '25 Dec '22 Dec '21 Dec '20 Mar '20 Mar '19 2014 - 2018
Market Capitalization
06481351100
Upgrade
Market Cap Growth
-96.53%-87.97%-64.22%23.20%22698.84%-69.23%
Upgrade
Enterprise Value
-10481361113
Upgrade
Last Close Price
0.010.756.2518.7517.5010.00
Upgrade
PS Ratio
--90621.21965.8112014.36-
Upgrade
PB Ratio
-0.05-1.85-35.02-12080.64-80.47-0.15
Upgrade
EV/Sales Ratio
--90562.69968.9512134.35-
Upgrade
Debt / Equity Ratio
-1.38-1.22-1.44-90.55-0.89-0.93
Upgrade
Asset Turnover
--0-0.04-
Upgrade
Inventory Turnover
--0.00---
Upgrade
Quick Ratio
0.02-0.060.410.090.00
Upgrade
Current Ratio
0.070.050.140.570.100.00
Upgrade
Return on Assets (ROA)
-12.91%-35.45%-73.26%--121.38%-769.19%
Upgrade
Return on Capital (ROIC)
-35.67%-122.14%-169.32%---
Upgrade
Earnings Yield
42.39%-30.82%-5.93%-1.75%-0.57%-72.43%
Upgrade
FCF Yield
-178.61%-20.45%-5.17%-1.47%-0.17%-22.15%
Upgrade
Buyback Yield / Dilution
-2.65%-1.54%-14.77%-176.87%-4885.43%51.18%
Upgrade
Updated Aug 14, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.